Home » Analyst Articles – US

Image for Elastic (NYSE:ESTC) Coverage Initiated by Analysts at Sumitomo Mitsui Financial Group

Elastic (NYSE:ESTC) Coverage Initiated by Analysts at Sumitomo Mitsui Financial Group

Sumitomo Mitsui Financial Group began coverage on shares of Elastic (NYSE:ESTC) in a report released on Wednesday, Briefing.com reports. The brokerage issued an outperform rating and a $150.00 price target on the stock. A number of... More of this article »
Image for Raven Industries (NASDAQ:RAVN) Upgraded at Zacks Investment Research

Raven Industries (NASDAQ:RAVN) Upgraded at Zacks Investment Research

Raven Industries (NASDAQ:RAVN) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Wednesday, Zacks.com reports. The brokerage presently has a $48.00 target... More of this article »
Image for Citigroup Cuts The Boston Beer (NYSE:SAM) Price Target to $1,145.00

Citigroup Cuts The Boston Beer (NYSE:SAM) Price Target to $1,145.00

The Boston Beer (NYSE:SAM) had its price target trimmed by Citigroup from $1,395.00 to $1,145.00 in a report published on Wednesday, The Fly reports. The brokerage currently has a neutral rating on the stock. SAM has been the topic... More of this article »
Image for TAL Education Group (NYSE:TAL) Downgraded by Morgan Stanley to “Underweight”

TAL Education Group (NYSE:TAL) Downgraded by Morgan Stanley to “Underweight”

Morgan Stanley lowered shares of TAL Education Group (NYSE:TAL) from an overweight rating to an underweight rating in a research report report published on Wednesday, The Fly reports. TAL has been the subject of several other research... More of this article »
Image for Piper Sandler Increases Oracle (NYSE:ORCL) Price Target to $80.00

Piper Sandler Increases Oracle (NYSE:ORCL) Price Target to $80.00

Oracle (NYSE:ORCL) had its price objective upped by analysts at Piper Sandler from $57.00 to $80.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “neutral” rating on the enterprise... More of this article »
Image for Barclays Increases Oracle (NYSE:ORCL) Price Target to $83.00

Barclays Increases Oracle (NYSE:ORCL) Price Target to $83.00

Oracle (NYSE:ORCL) had its price target upped by equities researchers at Barclays from $80.00 to $83.00 in a research note issued on Wednesday, Price Targets.com reports. The brokerage presently has an “equal weight” rating... More of this article »
Image for Banco Bilbao Vizcaya Argentaria (NYSE:BBVA) Upgraded at Societe Generale

Banco Bilbao Vizcaya Argentaria (NYSE:BBVA) Upgraded at Societe Generale

Banco Bilbao Vizcaya Argentaria (NYSE:BBVA) was upgraded by investment analysts at Societe Generale from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, The... More of this article »
Image for Citigroup Initiates Coverage on ZIM Integrated Shipping Services (NYSE:ZIM)

Citigroup Initiates Coverage on ZIM Integrated Shipping Services (NYSE:ZIM)

Research analysts at Citigroup began coverage on shares of ZIM Integrated Shipping Services (NYSE:ZIM) in a research note issued to investors on Wednesday, The Fly reports. The brokerage set a “buy” rating on the stock. A... More of this article »
Image for Alexandria Real Estate Equities (NYSE:ARE) Price Target Raised to $205.00 at Royal Bank of Canada

Alexandria Real Estate Equities (NYSE:ARE) Price Target Raised to $205.00 at Royal Bank of Canada

Alexandria Real Estate Equities (NYSE:ARE) had its target price raised by equities research analysts at Royal Bank of Canada from $202.00 to $205.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently... More of this article »
Image for Equinor ASA (NYSE:EQNR) Rating Lowered to Hold at Danske

Equinor ASA (NYSE:EQNR) Rating Lowered to Hold at Danske

Equinor ASA (NYSE:EQNR) was downgraded by research analysts at Danske from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday, The Fly reports. EQNR has been the topic of a number of... More of this article »
Image for Pets at Home Group (OTCMKTS:PAHGF) Upgraded to “Buy” by Liberum Capital

Pets at Home Group (OTCMKTS:PAHGF) Upgraded to “Buy” by Liberum Capital

Pets at Home Group (OTCMKTS:PAHGF) was upgraded by stock analysts at Liberum Capital from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, The Fly reports. Several other... More of this article »
Image for Intrum AB (publ) (OTCMKTS:ITJTY) Rating Increased to Overweight at JPMorgan Chase & Co.

Intrum AB (publ) (OTCMKTS:ITJTY) Rating Increased to Overweight at JPMorgan Chase & Co.

Intrum AB (publ) (OTCMKTS:ITJTY) was upgraded by stock analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a report issued on Wednesday, The Fly reports. Shares of ITJTY... More of this article »
Image for Sage Therapeutics (NASDAQ:SAGE) Downgraded by Citigroup to Neutral

Sage Therapeutics (NASDAQ:SAGE) Downgraded by Citigroup to Neutral

Sage Therapeutics (NASDAQ:SAGE) was downgraded by research analysts at Citigroup from a “buy” rating to a “neutral” rating in a research note issued on Wednesday, The Fly reports. Several other research analysts... More of this article »
Image for Pangaea Logistics Solutions (NASDAQ:PANL) Lifted to Buy at Zacks Investment Research

Pangaea Logistics Solutions (NASDAQ:PANL) Lifted to Buy at Zacks Investment Research

Pangaea Logistics Solutions (NASDAQ:PANL) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Wednesday, Zacks.com reports. The firm presently has... More of this article »
Image for nVent Electric (NYSE:NVT) Stock Rating Lowered by Zacks Investment Research

nVent Electric (NYSE:NVT) Stock Rating Lowered by Zacks Investment Research

nVent Electric (NYSE:NVT) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “nVent Electric... More of this article »
Image for Squarespace (NYSE:SQSP) Now Covered by Mizuho

Squarespace (NYSE:SQSP) Now Covered by Mizuho

Mizuho assumed coverage on shares of Squarespace (NYSE:SQSP) in a research note issued to investors on Tuesday, The Fly reports. The brokerage issued a buy rating on the stock. Other research analysts have also issued research reports... More of this article »
Image for CRISPR Therapeutics (NASDAQ:CRSP) Lifted to Neutral at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell

CRISPR Therapeutics (NASDAQ:CRSP) Lifted to Neutral at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell

CRISPR Therapeutics (NASDAQ:CRSP) was upgraded by investment analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell from a “sell” rating to a “neutral” rating in a note issued to... More of this article »
Image for Apple Hospitality REIT (NYSE:APLE) Given New $17.00 Price Target at B. Riley

Apple Hospitality REIT (NYSE:APLE) Given New $17.00 Price Target at B. Riley

Apple Hospitality REIT (NYSE:APLE) had its target price hoisted by B. Riley from $16.00 to $17.00 in a research note issued to investors on Tuesday morning, The Fly reports. They currently have a neutral rating on the real estate investment... More of this article »
Image for Nestlé (OTCMKTS:NSRGY) Upgraded to “Neutral” by BNP Paribas

Nestlé (OTCMKTS:NSRGY) Upgraded to “Neutral” by BNP Paribas

BNP Paribas upgraded shares of Nestlé (OTCMKTS:NSRGY) from an underperform rating to a neutral rating in a report released on Tuesday morning, Analyst Ratings Network reports. NSRGY has been the subject of a number of other reports.... More of this article »
Image for Bruker (NASDAQ:BRKR) Upgraded to Buy by Cleveland Research

Bruker (NASDAQ:BRKR) Upgraded to Buy by Cleveland Research

Cleveland Research upgraded shares of Bruker (NASDAQ:BRKR) from a neutral rating to a buy rating in a research report report published on Tuesday, Price Targets.com reports. Other equities research analysts have also recently issued... More of this article »
Image for Gladstone Commercial (NASDAQ:GOOD) PT Raised to $25.00

Gladstone Commercial (NASDAQ:GOOD) PT Raised to $25.00

Gladstone Commercial (NASDAQ:GOOD) had its price objective hoisted by B. Riley from $23.00 to $25.00 in a research report report published on Tuesday, The Fly reports. The brokerage currently has a buy rating on the real estate investment... More of this article »
Image for Kirby (NYSE:KEX) Upgraded to “Hold” at Zacks Investment Research

Kirby (NYSE:KEX) Upgraded to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Kirby (NYSE:KEX) from a sell rating to a hold rating in a report released on Tuesday morning, Zacks.com reports. The brokerage currently has $69.00 target price on the shipping company’s... More of this article »
Image for MorphoSys (NASDAQ:MOR) Given “Hold” Rating at HSBC

MorphoSys (NASDAQ:MOR) Given “Hold” Rating at HSBC

HSBC reissued their hold rating on shares of MorphoSys (NASDAQ:MOR) in a research report report published on Tuesday morning, The Fly reports. Other equities analysts have also recently issued research reports about the stock. SVB... More of this article »
Image for Healthpeak Properties (NYSE:PEAK) Price Target Increased to $39.00 by Analysts at Argus

Healthpeak Properties (NYSE:PEAK) Price Target Increased to $39.00 by Analysts at Argus

Healthpeak Properties (NYSE:PEAK) had its target price upped by Argus from $34.00 to $39.00 in a report released on Tuesday morning, The Fly reports. Argus currently has a buy rating on the stock. PEAK has been the topic of several... More of this article »
Image for Unitil (NYSE:UTL) Downgraded by Zacks Investment Research

Unitil (NYSE:UTL) Downgraded by Zacks Investment Research

Zacks Investment Research downgraded shares of Unitil (NYSE:UTL) from a buy rating to a hold rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, “Unitil Corporation is a registered public utility holding... More of this article »
Image for Adamis Pharmaceuticals (NASDAQ:ADMP) Downgraded by Zacks Investment Research to Strong Sell

Adamis Pharmaceuticals (NASDAQ:ADMP) Downgraded by Zacks Investment Research to Strong Sell

Zacks Investment Research cut shares of Adamis Pharmaceuticals (NASDAQ:ADMP) from a hold rating to a strong sell rating in a research report report published on Tuesday morning, Zacks.com reports. According to Zacks, “Adamis... More of this article »
Image for CVB Financial (NASDAQ:CVBF) Upgraded to “Buy” at Zacks Investment Research

CVB Financial (NASDAQ:CVBF) Upgraded to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of CVB Financial (NASDAQ:CVBF) from a hold rating to a buy rating in a research note published on Tuesday morning, Zacks.com reports. The brokerage currently has $24.00 price objective on the... More of this article »
Image for Fluent (NASDAQ:FLNT) Rating Increased to Hold at Zacks Investment Research

Fluent (NASDAQ:FLNT) Rating Increased to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Fluent (NASDAQ:FLNT) from a sell rating to a hold rating in a report released on Tuesday morning, Zacks.com reports. According to Zacks, “Fluent Inc. provides data-driven performance... More of this article »
Image for B. Riley Boosts Service Properties Trust (NASDAQ:SVC) Price Target to $15.00

B. Riley Boosts Service Properties Trust (NASDAQ:SVC) Price Target to $15.00

Service Properties Trust (NASDAQ:SVC) had its target price boosted by B. Riley from $13.00 to $15.00 in a research note issued to investors on Tuesday morning, The Fly reports. The brokerage currently has a neutral rating on the real... More of this article »
Image for Natera (NASDAQ:NTRA) Coverage Initiated by Analysts at Raymond James

Natera (NASDAQ:NTRA) Coverage Initiated by Analysts at Raymond James

Raymond James initiated coverage on shares of Natera (NASDAQ:NTRA) in a report published on Tuesday, Price Targets.com reports. The brokerage issued a market perform rating on the medical research company’s stock. Several other... More of this article »
Image for CRISPR Therapeutics (NASDAQ:CRSP) Lifted to “Neutral” at Citigroup

CRISPR Therapeutics (NASDAQ:CRSP) Lifted to “Neutral” at Citigroup

CRISPR Therapeutics (NASDAQ:CRSP) was upgraded by Citigroup from a “sell” rating to a “neutral” rating in a note issued to investors on Monday, The Fly reports. The firm presently has a $132.00 price target... More of this article »
Image for CatchMark Timber Trust (NYSE:CTT) Upgraded by Zacks Investment Research to Buy

CatchMark Timber Trust (NYSE:CTT) Upgraded by Zacks Investment Research to Buy

Zacks Investment Research upgraded shares of CatchMark Timber Trust (NYSE:CTT) from a hold rating to a buy rating in a research note issued to investors on Tuesday morning, Zacks.com reports. The firm currently has $13.00 price objective... More of this article »
Image for Compañía Cervecerías Unidas (NYSE:CCU) Lifted to Neutral at JPMorgan Chase & Co.

Compañía Cervecerías Unidas (NYSE:CCU) Lifted to Neutral at JPMorgan Chase & Co.

JPMorgan Chase & Co. upgraded shares of Compañía Cervecerías Unidas (NYSE:CCU) from an underweight rating to a neutral rating in a report issued on Tuesday morning, Analyst Price Targets reports. They currently have $20.60... More of this article »
Image for Swiss Prime Site (OTCMKTS:SWPRF) Earns “Neutral” Rating from Credit Suisse Group

Swiss Prime Site (OTCMKTS:SWPRF) Earns “Neutral” Rating from Credit Suisse Group

Credit Suisse Group reiterated their neutral rating on shares of Swiss Prime Site (OTCMKTS:SWPRF) in a report issued on Tuesday, The Fly reports. Shares of SWPRF opened at $102.35 on Tuesday. Swiss Prime Site Company Profile Swiss... More of this article »
Image for Deutsche Wohnen (OTCMKTS:DWHHF) Downgraded by Zacks Investment Research to “Hold”

Deutsche Wohnen (OTCMKTS:DWHHF) Downgraded by Zacks Investment Research to “Hold”

Zacks Investment Research lowered shares of Deutsche Wohnen (OTCMKTS:DWHHF) from a buy rating to a hold rating in a report released on Tuesday morning, Zacks.com reports. According to Zacks, “Deutsche Wohnen AG develops, manages... More of this article »
Image for SSP Group (OTCMKTS:SSPPF) Upgraded by Kepler Capital Markets to Buy

SSP Group (OTCMKTS:SSPPF) Upgraded by Kepler Capital Markets to Buy

Kepler Capital Markets upgraded shares of SSP Group (OTCMKTS:SSPPF) from a hold rating to a buy rating in a report issued on Tuesday morning, The Fly reports. A number of other brokerages also recently weighed in on SSPPF. Morgan Stanley... More of this article »
Image for Bird Construction (OTCMKTS:BIRDF) Downgraded to “Sector Perform” at National Bank Financial

Bird Construction (OTCMKTS:BIRDF) Downgraded to “Sector Perform” at National Bank Financial

National Bank Financial downgraded shares of Bird Construction (OTCMKTS:BIRDF) from an outperform rating to a sector perform rating in a report published on Tuesday, The Fly reports. A number of other research analysts have also recently... More of this article »
Image for CEMEX (NYSE:CX) Coverage Initiated by Analysts at Berenberg Bank

CEMEX (NYSE:CX) Coverage Initiated by Analysts at Berenberg Bank

Berenberg Bank initiated coverage on shares of CEMEX (NYSE:CX) in a research report released on Tuesday morning, Price Targets.com reports. The firm issued a buy rating on the construction company’s stock. Several other brokerages... More of this article »
Image for LVMH Moët Hennessy – Louis Vuitton, Société Européenne (OTCMKTS:LVMUY) Cut to “Hold” at Zacks Investment Research

LVMH Moët Hennessy – Louis Vuitton, Société Européenne (OTCMKTS:LVMUY) Cut to “Hold” at Zacks Investment Research

LVMH Moët Hennessy – Louis Vuitton, Société Européenne (OTCMKTS:LVMUY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday,... More of this article »
Image for The Lovesac (NASDAQ:LOVE) Upgraded by Zacks Investment Research to Buy

The Lovesac (NASDAQ:LOVE) Upgraded by Zacks Investment Research to Buy

The Lovesac (NASDAQ:LOVE) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. The brokerage... More of this article »
Image for Zacks Investment Research Upgrades Tsakos Energy Navigation (NYSE:TNP) to Hold

Zacks Investment Research Upgrades Tsakos Energy Navigation (NYSE:TNP) to Hold

Tsakos Energy Navigation (NYSE:TNP) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Tuesday, Zacks.com reports. According to Zacks, “Tsakos Energy... More of this article »
Image for SK Telecom Co.,Ltd (NYSE:SKM) Rating Increased to Buy at Zacks Investment Research

SK Telecom Co.,Ltd (NYSE:SKM) Rating Increased to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of SK Telecom Co.,Ltd (NYSE:SKM) from a hold rating to a buy rating in a research report sent to investors on Tuesday, Zacks.com reports. They currently have $37.00 target price on the Wireless... More of this article »
Image for SK Telecom Co.,Ltd (NYSE:SKM) Upgraded to “Buy” by Zacks Investment Research

SK Telecom Co.,Ltd (NYSE:SKM) Upgraded to “Buy” by Zacks Investment Research

Zacks Investment Research upgraded shares of SK Telecom Co.,Ltd (NYSE:SKM) from a hold rating to a buy rating in a research report sent to investors on Tuesday, Zacks.com reports. They currently have $37.00 target price on the Wireless... More of this article »
Image for NeuroBo Pharmaceuticals (NASDAQ:NRBO) Upgraded to “Buy” at Zacks Investment Research

NeuroBo Pharmaceuticals (NASDAQ:NRBO) Upgraded to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of NeuroBo Pharmaceuticals (NASDAQ:NRBO) from a hold rating to a buy rating in a report released on Tuesday, Zacks.com reports. The firm currently has $3.50 price target on the stock. According... More of this article »
Image for NeuroBo Pharmaceuticals (NASDAQ:NRBO) Upgraded to “Buy” at Zacks Investment Research

NeuroBo Pharmaceuticals (NASDAQ:NRBO) Upgraded to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of NeuroBo Pharmaceuticals (NASDAQ:NRBO) from a hold rating to a buy rating in a report released on Tuesday, Zacks.com reports. The firm currently has $3.50 price target on the stock. According... More of this article »
Image for Safran (OTCMKTS:SAFRY) Given “Buy” Rating at Berenberg Bank

Safran (OTCMKTS:SAFRY) Given “Buy” Rating at Berenberg Bank

Berenberg Bank restated their buy rating on shares of Safran (OTCMKTS:SAFRY) in a research note published on Tuesday, The Fly reports. A number of other equities analysts have also recently weighed in on the stock. Morgan Stanley... More of this article »
Image for The Coca-Cola (NYSE:KO) PT Raised to $62.00 at Credit Suisse Group

The Coca-Cola (NYSE:KO) PT Raised to $62.00 at Credit Suisse Group

The Coca-Cola (NYSE:KO) had its price objective increased by Credit Suisse Group from $60.00 to $62.00 in a report released on Tuesday morning, The Fly reports. They currently have an outperform rating on the stock. Other equities... More of this article »
Image for American Airlines Group (NASDAQ:AAL) PT Raised to $21.50 at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell

American Airlines Group (NASDAQ:AAL) PT Raised to $21.50 at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell

American Airlines Group (NASDAQ:AAL) had its price target lifted by equities researchers at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell from $21.00 to $21.50 in a research note issued on Monday, Analyst... More of this article »
Image for The Beauty Health (NASDAQ:SKIN) Coverage Initiated by Analysts at Canaccord Genuity

The Beauty Health (NASDAQ:SKIN) Coverage Initiated by Analysts at Canaccord Genuity

Canaccord Genuity assumed coverage on shares of The Beauty Health (NASDAQ:SKIN) in a research report sent to investors on Tuesday, Price Targets.com reports. The brokerage issued a buy rating and a $21.00 price target on the stock. Separately,... More of this article »
Image for SPX (NYSE:SPXC) Given “Buy” Rating at Oppenheimer

SPX (NYSE:SPXC) Given “Buy” Rating at Oppenheimer

Oppenheimer reissued their buy rating on shares of SPX (NYSE:SPXC) in a research report released on Tuesday, Analyst Ratings Network reports. Oppenheimer currently has a $72.00 target price on the stock. Several other brokerages have... More of this article »